Concepedia

Susan R. Opalenik

SR

Statistics

Publications

31

Citations

2.8K

H-Index

22

Active since

1995

Affiliations

Vanderbilt University(Current)

Vanderbilt University Medical Center

University of Alabama at Birmingham

VA Tennessee Valley Healthcare System

Sidney Kimmel Comprehensive Cancer Center

Susan R. Opalenik is an author at Vanderbilt University specializing in life sciences, molecular biology, and oncology.

ORCID

Publications per year

1995–2024

31

Publications

31

Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

Douglas B. Johnson, Mónica V. Estrada, Roberto Salgado et al. · Nature Communications · 2016 · 572 citations · Full text

, , +17

T cells specific for α-myosin drive immunotherapy-related myocarditis

Margaret L. Axelrod, Wouter C. Meijers, Elles M. Screever et al. · Nature · 2022 · 321 citations · Full text

, , +14

DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer

Na Luo, Mellissa J. Nixon, Paula I. González-Ericsson et al. · Nature Communications · 2018 · 271 citations · Full text

, , +17

Gene Profiling of Keloid Fibroblasts Shows Altered Expression in Multiple Fibrosis-Associated Pathways

Joan C. Smith, Braden Boone, Susan R. Opalenik et al. · Journal of Investigative Dermatology · 2007 · 169 citations · Full text

, , +16

Epigenetically Altered Wound Healing in Keloid Fibroblasts

Shirley B. Russell, James Russell, Kathryn M. Trupin et al. · Journal of Investigative Dermatology · 2010 · 165 citations · Full text

, , +14

1–5 of 31